Table 3.
Characteristics of Kidney injury molecule-1 (Kim-1)*
| Parameters | Description | |
|---|---|---|
| Other names | Hepatitis A virus cellular receptor-1 (HAVCR-1), T cell immunoglobulin like molecule-1 (TIM-1), cochlear injury molecule-1 (CIM-1) | |
| Chromosomal location | Human (5q31), chimpanzee (5), rat (10q21), mouse (11B1.1) | |
| Molecular mass | Human (359 aa), chimpanzee (predicted: 357 aa), rat (307 aa), mouse (305 aa) | |
| Structure | Immunoglobulin domain, threonine-serine-proline-rich mucin domain, transmembrane domain, short cytoplasmic tail | |
| Number of KIM-1 homologues | Human (three: KIM-1, KIM-3, KIM-4), rat (six: Kim-1 to Kim-6), mouse (eight: Kim-1 to Kim-8) | |
| % Identity of human KIM-1 protein | Chimpanzee (79%), rat (39%), mouse (37%) | |
| Upregulation in kidney injury/toxicity/dedifferentiation models | Adriamycin-nephrosis | Ischemia/reperfusion |
| Brain dead donor rat kidney | Kidney fibrosis | |
| Cadmium | Mercuric chloride | |
| Chromium | Ochratoxin | |
| Cisplatin | Polycystic kidney disease | |
| Cyclosporine | Protein-overload | |
| Endotoxin | Renal cell carcinoma | |
| Folic acid | Sevoflurane | |
| Gentamicin | S-(1,1,2,2-tetrafluoroethyl)-l-cysteine (TFEC) | |
Adapted and modified from Vaidya and Bonventre, 2006 (27).